Lupin Launches Postmenopausal Osteoporosis Prevention Tablets In US Market

New Delhi: Drug major Lupin on Tuesday said it has launched Amabelz tablets, used in prevention of postmenopausal osteoporosis, in the American market after getting approval from the US US health regulator - the US Food and Drug Administration (FDA). Lupin Pharmaceuticals Inc, a subsidiary of the company, has launched Amabelz tablets, a generic version of Amneal Pharmaceuticals' Activella tablets, in the US, Lupin said in a statemen...